Hedge Fund - Octagon Capital Advisors
Arcus Biosciences Inc. (RCUS)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2023 - Q4 (2023-12-31) | $35,678,800 | 5.7% | 1,868,000 | $15.98 |
2 | 2023 - Q3 (2023-09-30) | $35,325,600 | 5.42% | 1,968,000 | $20.09 |
3 | 2023 - Q2 (2023-06-30) | $39,970,080 | 5.56% | 1,968,000 | $19.04 |
4 | 2023 - Q1 (2023-03-31) | $39,617,280 | 5.7% | 2,172,000 | $19.11 |
5 | 2022 - Q4 (2022-12-31) | $51,342,236 | 7.99% | 2,482,700 | $27.52 |
6 | 2022 - Q3 (2022-09-30) | $69,803,000 | 12.04% | 2,668,316 | $26.45 |
7 | 2022 - Q2 (2022-06-30) | $67,657,000 | 18.05% | 2,669,974 | $24.49 |
8 | 2022 - Q1 (2022-03-31) | $78,584,000 | 16.98% | 2,489,974 | $33.51 |
9 | 2021 - Q4 (2021-12-31) | $84,794,000 | 16.5% | 2,095,231 | $38.79 |
10 | 2021 - Q3 (2021-09-30) | $33,830,000 | 8.32% | 970,164 | $31.12 |
11 | 2021 - Q2 (2021-06-30) | $20,874,000 | 4.32% | 760,164 | $28.56 |
12 | 2021 - Q1 (2021-03-31) | $11,232,000 | 4.23% | 400,000 | $34.80 |
13 | 2020 - Q4 (2020-12-31) | $7,788,000 | 2.69% | 300,000 | $24.20 |
The displayed share prices are average quarterly stock market prices.